Edition:
United States

TSO3 Inc (TOS.TO)

TOS.TO on Toronto Stock Exchange

2.96CAD
26 May 2017
Change (% chg)

$-0.03 (-1.00%)
Prev Close
$2.99
Open
$2.97
Day's High
$2.98
Day's Low
$2.95
Volume
73,236
Avg. Vol
154,965
52-wk High
$3.82
52-wk Low
$2.08

Latest Key Developments (Source: Significant Developments)

TSO3 reports Q1 loss per share $0.02
Wednesday, 10 May 2017 06:30am EDT 

May 10 (Reuters) - TSO3 Inc : :TSO3 reports record first quarter 2017 results.TSO3 inc qtrly revenue increased to a record $4.2 million, a 13.5pct sequential increase over $3.7 million recorded in Q4 of 2016.Q1 loss per share $0.02.Q1 earnings per share view $-0.01, revenue view $4.1 million -- Thomson Reuters I/B/E/S.  Full Article

TSO3 qtrly loss per share $0.02
Tuesday, 21 Mar 2017 06:30am EDT 

TSO3 Inc : TSO3 reports record fourth quarter and full year 2016 results . Qtrly revenue increased to $3.75 million compared to $0.15 million in same period last year . TSO3 Inc qtrly loss per share $0.02 . Q4 earnings per share view $-0.01, revenue view $2.8 million -- Thomson Reuters I/B/E/S .TSO3 Inc - "2017 will also see us expand upon use of our existing laboratories in Québec and South Carolina".  Full Article

TSO3 reports Q2 loss per share $0.02
Wednesday, 3 Aug 2016 06:30am EDT 

TSO3 Inc : Q2 loss per share $0.02 .Revenues were $3.0 million in Q2 2016 versus $3.1 million in Q1 2016 and $0.1 million in Q2 2015..  Full Article

TSO3 responds to U.S. FDA on extended claims, gives operations update
Wednesday, 1 Jun 2016 05:00pm EDT 

Tso3 Inc : TSO3 responds to u.s. Regulators on extended claims and provides operations update . Responded to a previously announced request for additional information by U.S. Food and Drug Administration . Co's response allows FDA to continue their review for market clearance on extended claims for sterizone VP4 sterilizer in U.S. . Production and operational improvements co made on assembly facility had a minimal impact on Q2 2016 production . Substantially completed its improvements to its manufacturing facility in Québec .Operational improvements to its assembly facility are designed to increase assembly capacity and efficiency.  Full Article

TSO3 appoints Glen Kayll as Chief Financial Officer
Friday, 18 Dec 2015 07:00am EST 

TSO3 Inc:Appointed Glen Kayll as Chief Financial Officer.Kayll succeeds Éléna Simard-Veilleux, who had been acting as interim CFO and has been appointed to the new position of vice president of finance.  Full Article

new interim chief financial officer appointed at TSO3
Friday, 24 Jul 2015 04:05pm EDT 

TSO3 Inc:Announced the appointment of Elena Simard-Veilleux, to the position of Interim Chief Financial Officer effective immediately.Simard-Veilleux replaces Benoît Deschamps.  Full Article

TSO3 Inc receives purchase orders for its STERIZONE sterilization system - Begins shipment of STERIZONE VP4 Sterilizers to USA
Friday, 24 Jul 2015 06:30am EDT 

TSO3 Inc:Has received purchase orders for multiple devices from US.Says orders are result of collaborative relationship between Getinge infection control, its sales and service provider, and company.  Full Article

TSO3 announces formation of a unit
Monday, 6 Jul 2015 06:30am EDT 

TSO3 Inc:Says formation of a wholly owned subsidiary: TSO3Corporation in the State of South Carolina, USA.Says new location is expected to open in August of this year in time to meet US customer requirements.  Full Article

More From Around the Web

BRIEF-TSO3 reports Q1 loss per share $0.02

* TSO3 inc qtrly revenue increased to a record $4.2 million, a 13.5pct sequential increase over $3.7 million recorded in Q4 of 2016